COMP <GO>
XTNT vs SNWV // EV/EBITDA & P/E VALUATION
Xtant Medical Holdings Inc. (NYSE) VS. SANUWAVE Health Inc. (NASDAQ) • 15-METRIC TALLY: XTNT 3
— SNWV 7
▲ EV/EBITDA & P/E VALUATION LEADER: XTNT
LAST: $0.29 (+1.54%) • MKT CAP: $40.7M
valuation
3.7x
LAST: $5.27 (0.00%) • MKT CAP: $45.3M
valuation
7.5x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (XTNT VS. SNWV)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | XTNT | SNWV | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 62.90% | 77.10% | -14.20 | SNWV | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 12.80% | 67.30% | -54.50 | SNWV | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 3.7x | 7.5x | -3.80 | XTNT | /valuation <GO> |
| Free Cash Flow Yield | 24.95% | 4.27% | +20.68 | XTNT | /fcf-yield <GO> |
| Operating Margin | 5.40% | 11.20% | -5.80 | SNWV | /operating-margins <GO> |
| Net Profit Margin | 0.00% | 26.80% | -26.80 | SNWV | /net-margins <GO> |
| Revenue Growth (YoY) | 14.20% | 36.30% | -22.10 | SNWV | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 7/9 | +2.00 | XTNT | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 34.9 | 50.4 | -15.42 | SNWV | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 3.5x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $40.7M | $45.3M | -$4.6M | SNWV | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | XTNT REV | SNWV REV | XTNT GROSS % | SNWV GROSS % | XTNT FCF | SNWV FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $133.9M | $44.1M | 62.9% | 77.1% | $10.2M | $1.9M |
| FY 2024 | $117.3M | $32.3M | 58.2% | 75.9% | -$16.0M | $2.0M |
| FY 2023 | $91.3M | $19.3M | — | — | -$9.5M | -$4.5M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
XTNT // BETA —
SNWV // BETA —